Nicotinic acetylcholine receptors and predisposition to lung cancer

Current Opinion in Oncology

Volumn 23, Issue 1, 2011, Pages 83-87

  Tournier, Jean Marie ^a   Birembaut, Philippe ^a,b  

^a UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^b REIMS UNIVERSITY HOSPITAL   (France)

Author keywords

Lung cancer; Nicotine dependence; Nicotinic acetylcholine receptor

Indexed keywords

BUNGAROTOXIN RECEPTOR; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 12; INTERLEUKIN 6; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR ALPHA10; NICOTINIC RECEPTOR ALPHA3; NICOTINIC RECEPTOR ALPHA4BETA2; NICOTINIC RECEPTOR ALPHA5; NICOTINIC RECEPTOR BETA2; NICOTINIC RECEPTOR BETA4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CANCER SUSCEPTIBILITY; CELL PROLIFERATION; CYTOKINE RELEASE; GENE CLUSTER; GENE LOCUS; GENETIC PREDISPOSITION; IMMUNITY; LUNG CANCER; LUNG CARCINOGENESIS; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SQUAMOUS CELL METAPLASIA; TOBACCO DEPENDENCE;

GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG NEOPLASMS; POLYMORPHISM, GENETIC; PRECANCEROUS CONDITIONS; RECEPTORS, NICOTINIC;

EID: 79851513033     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/CCO.0b013e3283412ea1     Document Type: Article

References (48)

1. Beasley MB, Brambilla E, Travis WD. The 2004 World Health Organization classification of lung tumors. Semin Roentgenol 2005; 40:90-97.
2. Burns DM. Tobacco-related diseases. Semin Oncol Nurs 2003; 19:244-249. (Pubitemid 38609563)
3. Hecht SS. Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 1999; 91:1194-1210. (Pubitemid 29357186)
4. Sobel A, Weber M, Changeux JP. Large-scale purification of the acetylcho-line-receptor protein in its membrane-bound and detergent-extracted forms from Torpedo marmorata electric organ. Eur J Biochem 1977; 80:215-224. (Pubitemid 8210000)
5. Galzi JL, Revah F, Bessis A, Changeux JP. Functional architecture of the nicotinic acetylcholine receptor: from electric organ to brain. Annu Rev Pharmacol Toxicol 1991; 31:37-72. (Pubitemid 21903841)
6. McGehee DS, Role LW. Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annu Rev Physiol 1995; 57:521-546.
7. Wessler I, Kirkpatrick CJ, Racke K. Nonneuronal acetylcholine, a locally acting molecule, widely distributed in biological systems: expression and function in humans. Pharmacol Ther 1998; 77:59-79. (Pubitemid 28059940)
8. Kummer W, Lips KS, Pfeil U. The epithelial cholinergic system of the airways. Histochem Cell Biol 2008; 130:219-234.
9. Schuller HM, Orloff M. Tobacco-specific carcinogenic nitrosamines. Ligands for nicotinic acetylcholine receptors in human lung cancer cells. Biochem Pharmacol 1998; 55:1377-1384. (Pubitemid 28298517)
10. Lindstrom J, Anand R, Gerzanich V, et al. Structure and function of neuronal nicotinic acetylcholine receptors. Prog Brain Res 1996; 109:125-137. (Pubitemid 27047080)
11. Gotti C, Clementi F. Neuronal nicotinic receptors: from structure to pathology. Prog Neurobiol 2004; 74:363-396. (Pubitemid 40092737)
12. Di CG, Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci U S A 1988; 85:5274-5278.
13. Calabresi P, Lacey MG, North RA. Nicotinic excitation of rat ventral tegmental neurones in vitro studied by intracellular recording. Br J Pharmacol 1989; 98:135-140. (Pubitemid 19225212)
14. Pontieri FE, Tanda G, Orzi F, Di CG. Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature 1996; 382: 255-257. (Pubitemid 26251360)
15. Pidoplichko VI, DeBiasi M, Williams JT, Dani JA. Nicotine activates and desensitizes midbrain dopamine neurons. Nature 1997; 390:401-404. (Pubitemid 28027320)
16. Salas R, Main A, Gangitano D, De BM. Decreased withdrawal symptoms but normal tolerance to nicotine in mice null for the alpha7 nicotinic acetylcholine receptor subunit. Neuropharmacology 2007; 53:863-869. (Pubitemid 350018825)
17. Jackson KJ, Martin BR, Changeux JP, Damaj MI. Differential role of nicotinic acetylcholine receptor subunits in physical and affective nicotine withdrawal signs. J Pharmacol Exp Ther 2008; 325:302-312. (Pubitemid 351439184)
18. Schuller HM. Is cancer triggered by altered signalling of nicotinic acetylcholine receptors? Nat Rev Cancer 2009; 9:195-205.
19. Hung RJ, McKay JD, Gaborieau V, et al. A susceptibility locus for lung cancermaps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 2008; 452:633-637. (Pubitemid 351483367)
20. Thorgeirsson TE, Geller F, Sulem P, et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 2008; 452:638-642. (Pubitemid 351483366)
21. Amos CI, Wu X, Broderick P, et al. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet 2008; 40:616-622. (Pubitemid 351601203)
22. Spitz MR, Amos CI, Dong Q, et al. The CHRNA5-A3 region on chromosome 15q24-25.1 is a risk factor both for nicotine dependence and for lung cancer. J Natl Cancer Inst 2008; 100:1552-1556.
23. Shiraishi K, Kohno T, Kunitoh H, et al. Contribution of nicotine acetylcholine receptor polymorphisms to lung cancer risk in a smoking-independent manner in the Japanese. Carcinogenesis 2009; 30:65-70.
24. Saccone SF, Hinrichs AL, Saccone NL, et al. Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Hum Mol Genet 2007; 16:36-49. (Pubitemid 46152543)
25. Weiss RB, Baker TB, Cannon DS, et al. A candidate gene approach identifies the CHRNA5 - A3 -B4 region as a risk factor for age-dependent nicotine addiction. PLoS Genet 2008; 4:e1000125.
26. Stevens VL, Bierut LJ, Talbot JT, et al. Nicotinic receptor gene variants influence susceptibility to heavy smoking. Cancer Epidemiol Biomarkers Prev 2008; 17:3517-3525.
27. Wang JC, Cruchaga C, Saccone NL, et al. Risk for nicotine dependence and lung cancer is conferred by mRNA expression levels and amino acid change in CHRNA5. Hum Mol Genet 2009; 18:3125-3135.
28. Bierut LJ, Stitzel JA, Wang JC, et al. Variants in nicotinic receptors and risk for nicotine dependence. Am J Psychiatry 2008; 165:1163-1171.
29. Paliwal A, Vaissiere T, Krais A, et al. Aberrant DNA methylation links cancer susceptibility locus 15q25.1 to apoptotic regulation and lung cancer. Cancer Res 2010; 70:2779-2788.
30. Wilson DO, Weissfeld JL, Balkan A, et al. Association of radiographic emphysema and airflow obstruction with lung cancer. Am J Respir Crit Care Med 2008; 178:738-744.
31. Pillai SG, Ge D, Zhu G, et al. A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. PLoS Genet 2009; 5:e1000421.
32. Le ML, Derby KS, Murphy SE, et al. Smokers with the CHRNA lung cancer-associated variants are exposed to higher levels of nicotine equivalents and a carcinogenic tobacco-specific nitrosamine. Cancer Res 2008; 68:9137-9140.
33. West KA, Brognard J, Clark AS, et al. Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells. J Clin Invest 2003; 111:81-90. (Pubitemid 36134851)
34. Egleton RD, Brown KC, Dasgupta P. Nicotinic acetylcholine receptors in cancer: multiple roles in proliferation and inhibition of apoptosis. Trends Pharmacol Sci 2008; 29:151-158.
35. Takahashi H, Ogata H, Nishigaki R, et al. Tobacco smoke promotes lung tumorigenesis by triggering IKKbeta- and JNK1-dependent inflammation. Cancer Cell 2010; 17:89-97.
36. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010; 140:883-899.
37. Plummer HK III, Dhar M, Schuller HM. Expression of the alpha7 nicotinic acetylcholine receptor in human lung cells. Respir Res 2005; 6:29.
38. Maouche K, Polette M, Jolly T, et al. {alpha}7 nicotinic acetylcholine receptor regulates airway epithelium differentiation by controlling basal cell proliferation. Am J Pathol 2009; 175:1868-1882.
39. Gwilt CR, Donnelly LE, Rogers DF. The nonneuronal cholinergic system in the airways: an unappreciated regulatory role in pulmonary inflammation? Pharmacol Ther 2007; 115:208-222. (Pubitemid 47042914)
40. Martinez-Garcia E, Irigoyen M, Anso E, et al. Recurrent exposure to nicotine differentiates human bronchial epithelial cells via epidermal growth factor receptor activation. Toxicol Appl Pharmacol 2008; 228:334-342.
41. Wang H, Yu M, Ochani M, et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 2003; 421:384-388. (Pubitemid 36157937)
42. Fujii YX, Fujigaya H, Moriwaki Y, et al. Enhanced serum antigen-specific IgG1 and proinflammatory cytokine production in nicotinic acetylcholine receptor alpha7 subunit gene knockout mice. J Neuroimmunol 2007; 189:69-74. (Pubitemid 47379434)
43. Takahashi HK, Iwagaki H,Hamano R, etal.The immunosuppressive effects of nicotine during human mixed lymphocyte reaction. Eur J Pharmacol 2007; 559:69-74. (Pubitemid 46274647)
44. Papke RL, Kem WR, Soti F, et al. Activation and desensitization of nicotinic alpha7-type acetylcholine receptors by benzylidene anabaseines and nicotine. J Pharmacol Exp Ther 2009; 329:791-807.
45. Kawai H, Berg DK. Nicotinic acetylcholine receptors containing alpha 7 subunits on rat cortical neurons do not undergo long-lasting inactivation even when up-regulated by chronic nicotine exposure. J Neurochem 2001; 78: 1367-1378. (Pubitemid 32899768)
46. Quick MW, Lester RA. Desensitization of neuronal nicotinic receptors. J Neurobiol 2002; 53:457-478. (Pubitemid 35375579)
47. Al-Wadei HA, Al-Wadei MH, Masi T, Schuller HM. Chronic exposure to estrogen and the tobacco carcinogen NNK cooperatively modulates nicotinic receptors in small airway epithelial cells. Lung Cancer 2010; 69:33-39.
48. Paleari L, Negri E, Catassi A, et al. Inhibition of nonneuronal alpha7-nicotinic receptor for lung cancer treatment. Am J Respir Crit Care Med 2009; 179:1141-1150.